{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:38:46Z","timestamp":1769971126957,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,31]]},"DOI":"10.7759\/cureus.102758","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T07:28:16Z","timestamp":1769930896000},"source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Value of the Pre-treatment Albumin-to-Alkaline Phosphatase Ratio in Patients With Metastatic Colorectal Cancer"],"prefix":"10.7759","author":[{"given":"Hac\u0131","family":"Arak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ercan","family":"Gumusburun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Havva","family":"Yesil Cinkir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel RL","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023, 73:17-48. 10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes A","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, et al.. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023, 34:10-32. 10.1016\/j.annonc.2022.10.003","journal-title":"Ann Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2014.09.009","article-title":"Predictive and prognostic markers in the treatment of metastatic colorectal cancer (mCRC): personalized medicine at work","volume":"29","author":"Stintzing S","year":"2015","unstructured":"Stintzing S, Stremitzer S, Sebio A, Lenz HJ. Predictive and prognostic markers in the treatment of metastatic colorectal cancer (mCRC): personalized medicine at work. Hematol Oncol Clin North Am. 2015, 29:43-60. 10.1016\/j.hoc.2014.09.009","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102746","article-title":"Principles of molecular utility for CMS classification in colorectal cancer management","volume":"15","author":"Rejali L","year":"2023","unstructured":"Rejali L, Seifollahi Asl R, Sanjabi F, et al.. Principles of molecular utility for CMS classification in colorectal cancer management. Cancers (Basel). 2023, 15:10.3390\/cancers15102746","journal-title":"Cancers (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-07921-6","article-title":"Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible?","volume":"21","author":"An L","year":"2021","unstructured":"An L, Yin WT, Sun DW. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible?. BMC Cancer. 2021, 21:247. 10.1186\/s12885-021-07921-6","journal-title":"BMC Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3244","article-title":"Predictive value of pretreatment albumin-to-alkaline phosphatase ratio for overall survival for patients with advanced non-small cell lung cancer","volume":"9","author":"Zhou S","year":"2020","unstructured":"Zhou S, Jiang W, Wang H, Wei N, Yu Q. Predictive value of pretreatment albumin-to-alkaline phosphatase ratio for overall survival for patients with advanced non-small cell lung cancer. Cancer Med. 2020, 9:6268-80. 10.1002\/cam4.3244","journal-title":"Cancer Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v14.i5.1002","article-title":"Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer","volume":"14","author":"Li YT","year":"2022","unstructured":"Li YT, Zhou XS, Han XM, Tian J, Qin Y, Zhang T, Liu JL. Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer. World J Gastrointest Oncol. 2022, 14:1002-13. 10.4251\/wjgo.v14.i5.1002","journal-title":"World J Gastrointest Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7150\/jca.21799","article-title":"Albumin-to-alkaline phosphatase ratio as an independent prognostic factor for overall survival of advanced hepatocellular carcinoma patients without receiving standard anti-cancer therapies","volume":"9","author":"Cai X","year":"2018","unstructured":"Cai X, Chen Z, Chen J, et al.. Albumin-to-alkaline phosphatase ratio as an independent prognostic factor for overall survival of advanced hepatocellular carcinoma patients without receiving standard anti-cancer therapies. J Cancer. 2018, 9:189-97. 10.7150\/jca.21799","journal-title":"J Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21647","article-title":"Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting","volume":"8","author":"Riedl JM","year":"2017","unstructured":"Riedl JM, Posch F, Moik F, et al.. Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting. Oncotarget. 2017, 8:96048-61. 10.18632\/oncotarget.21647","journal-title":"Oncotarget"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-012-0802-0","article-title":"Hypoalbuminemia","volume":"7 Suppl 3","author":"Gatta A","year":"2012","unstructured":"Gatta A, Verardo A, Bolognesi M. Hypoalbuminemia. Intern Emerg Med. 2012, 7 Suppl 3:S193-9. 10.1007\/s11739-012-0802-0","journal-title":"Intern Emerg Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.37.2861","article-title":"5-Fluorouracil derivatives with serum protein binding potencies","volume":"37","author":"Yamashita S","year":"1989","unstructured":"Yamashita S, Suda Y, Masada M, Nadai T, Sumi M. 5-Fluorouracil derivatives with serum protein binding potencies. Chem Pharm Bull (Tokyo). 1989, 37:2861-3. 10.1248\/cpb.37.2861","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v7.i12.370","article-title":"Hypoalbuminemia in colorectal cancer prognosis: nutritional marker or inflammatory surrogate?","volume":"7","author":"Nazha B","year":"2015","unstructured":"Nazha B, Moussaly E, Zaarour M, Weerasinghe C, Azab B. Hypoalbuminemia in colorectal cancer prognosis: nutritional marker or inflammatory surrogate?. World J Gastrointest Surg. 2015, 7:370-7. 10.4240\/wjgs.v7.i12.370","journal-title":"World J Gastrointest Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-017-2907-4","article-title":"Preoperative alkaline phosphatase elevation was associated with poor survival in colorectal cancer patients","volume":"32","author":"Hung HY","year":"2017","unstructured":"Hung HY, Chen JS, Chien-YuhYeh, et al.. Preoperative alkaline phosphatase elevation was associated with poor survival in colorectal cancer patients. Int J Colorectal Dis. 2017, 32:1775-8. 10.1007\/s00384-017-2907-4","journal-title":"Int J Colorectal Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2015.12.008","article-title":"Differential expression of alkaline phosphatase gene in proliferating primary lymphocytes and malignant lymphoid cell lines","volume":"170","author":"Latheef SA","year":"2016","unstructured":"Latheef SA, Devanabanda M, Sankati S, Madduri R. Differential expression of alkaline phosphatase gene in proliferating primary lymphocytes and malignant lymphoid cell lines. Immunol Lett. 2016, 170:37-41. 10.1016\/j.imlet.2015.12.008","journal-title":"Immunol Lett"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107154","article-title":"NLR, d-NLR and PLR can be affected by many factors","volume":"90","author":"Bedel C","year":"2021","unstructured":"Bedel C, Korkut M, Arma\u011fan HH. NLR, d-NLR and PLR can be affected by many factors. Int Immunopharmacol. 2021, 90:107154. 10.1016\/j.intimp.2020.107154","journal-title":"Int Immunopharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6661097","article-title":"Prognostic value of pretreatment albumin-to-alkaline phosphatase ratio in cancer: a meta-analysis","volume":"2020","author":"Xie H","year":"2020","unstructured":"Xie H, Wei L, Tang S, Gan J. Prognostic value of pretreatment albumin-to-alkaline phosphatase ratio in cancer: a meta-analysis. Biomed Res Int. 2020, 2020:6661097. 10.1155\/2020\/6661097","journal-title":"Biomed Res Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/983698","article-title":"Neutrophils in cancer: two sides of the same coin","volume":"2015","author":"Uribe-Querol E","year":"2015","unstructured":"Uribe-Querol E, Rosales C. Neutrophils in cancer: two sides of the same coin. J Immunol Res. 2015, 2015:983698. 10.1155\/2015\/983698","journal-title":"J Immunol Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2016-0214","article-title":"The pretreatment thrombocytosis may predict prognosis of patients with colorectal cancer: a systematic review and meta-analysis","volume":"11","author":"Wang YH","year":"2017","unstructured":"Wang YH, Deng SJ, Yang YD, et al.. The pretreatment thrombocytosis may predict prognosis of patients with colorectal cancer: a systematic review and meta-analysis. Biomark Med. 2017, 11:195-210. 10.2217\/bmm-2016-0214","journal-title":"Biomark Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-011-1610-3","article-title":"Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy","volume":"68","author":"C\u00e9z\u00e9 N","year":"2011","unstructured":"C\u00e9z\u00e9 N, Thibault G, Goujon G, Viguier J, Watier H, Dorval E, Lecomte T. Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy. Cancer Chemother Pharmacol. 2011, 68:1305-13. 10.1007\/s00280-011-1610-3","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-1094-5","article-title":"Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis","volume":"20","author":"Zhao J","year":"2020","unstructured":"Zhao J, Huang W, Wu Y, et al.. Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis. Cancer Cell Int. 2020, 20:15. 10.1186\/s12935-020-1094-5","journal-title":"Cancer Cell Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-012-0439-x","article-title":"Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer","volume":"30","author":"He W","year":"2013","unstructured":"He W, Yin C, Guo G, et al.. Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol. 2013, 30:439. 10.1007\/s12032-012-0439-x","journal-title":"Med Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030901","article-title":"Prognostic value of preoperative albumin-to-alkaline phosphatase ratio for survival in colorectal cancer patients undergoing surgery","volume":"14","author":"Arak H","year":"2025","unstructured":"Arak H, Gumusburun E, Seyyar M, Yesil Cinkir H. Prognostic value of preoperative albumin-to-alkaline phosphatase ratio for survival in colorectal cancer patients undergoing surgery. J Clin Med. 2025, 14:2025. 10.3390\/jcm14030901","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S349996","article-title":"The neutrophil-to-albumin ratio as a new predictor of all-cause mortality in patients with heart failure","volume":"15","author":"Hu Z","year":"2022","unstructured":"Hu Z, Wang J, Xue Y, Zhang Q, Xu Q, Ji K, Yin R. The neutrophil-to-albumin ratio as a new predictor of all-cause mortality in patients with heart failure. J Inflamm Res. 2022, 15:701-13. 10.2147\/JIR.S349996","journal-title":"J Inflamm Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/454981-prognostic-value-of-the-pre-treatment-albumin-to-alkaline-phosphatase-ratio-in-patients-with-metastatic-colorectal-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T07:28:17Z","timestamp":1769930897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/454981-prognostic-value-of-the-pre-treatment-albumin-to-alkaline-phosphatase-ratio-in-patients-with-metastatic-colorectal-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.102758","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,31]]}}}